MktsMarkets

Lexeo Therapeutics, Inc.
NASDAQ: LXEOKey statistics
LXEO News
Stories mentioning LXEO from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 15,703 | 16,210 | 15,695 | 14,721 | 17,171 | 18,366 | 23,423 | 16,560 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 22,333 | 23,116 | 21,648 | 30,688 | 33,805 | 27,382 | 31,543 | 23,550 |
| Operating Income (Loss) | (22,333) | (23,116) | (21,648) | (30,688) | (33,805) | (27,382) | (31,543) | (23,550) |
| Interest Income | 2,113 | 2,213 | 1,456 | 1,268 | 1,193 | 1,465 | 2,092 | 2,348 |
| Interest Expense | 35.00 | |||||||
| Other Expense | (1.00) | 9.00 | (9.00) | (14.00) | (4.00) | 0.00 | (3.00) | (1.00) |
| Pretax Income | (20,196) | (20,628) | (20,283) | (26,103) | (32,656) | (26,027) | (29,489) | (21,238) |
| Tax Provision | ||||||||
| Net Income (Loss) | (20,196) | (20,919) | (20,283) | (26,103) | (32,656) | (25,924) | (29,489) | (21,238) |
| Earnings Per Share (Basic) | (0.25) | (0.39) | (0.33) | (0.60) | (0.99) | (0.82) | (0.89) | (0.64) |
| Earnings Per Share (Diluted) | (0.25) | (0.39) | (0.33) | (0.60) | (0.99) | (0.82) | (0.89) | (0.64) |
| Weighted Average Shares Outstanding (Basic) | 81,184 | 53,645 | 60,981 | 43,574 | 33,114 | 31,787 | 33,063 | 33,002 |
| Weighted Average Shares Outstanding (Diluted) | 81,184 | 53,645 | 60,981 | 43,574 | 33,114 | 31,787 | 33,063 | 33,002 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About LXEO
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) is a stock listed on the Nasdaq Stock Market under the ticker symbol LXEO. It last traded at $2.64 (Oct 16, 2026, 4:00 PM ET), down 4.3% on the day. That gives Lexeo Therapeutics a market capitalisation of $216.7M.
Over the past 52 weeks LXEO has traded between $2.56 and $10.99.
For the quarter ended Mar 31, 2026 it reported a net loss of $20.2M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$20.2M |
| Dec 31, 2025 | — | -$20.9M |
| Sep 30, 2025 | — | -$20.3M |
| Jun 30, 2025 | — | -$26.1M |
From Lexeo Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…